Evaluate Unique Device Identification compliance for FDA (21 CFR Part 801/830) and EU MDR (Article 27), covering UDI assignment, labeling, GUDID/EUDAMED registration
21 CFR 801.40: Must use accredited agency for UDI-DI and UDI-PI
801.20: UDI-DI identifies specific device model and labeler
801.20: UDI-PI identifies production unit (lot, serial, expiration, manufacturing date)
801.20(b): New UDI-DI required for changes affecting safety, performance, or identity
Label UDI on device itself and each level of packaging (unit, intermediate, shipping)
801.45(a): Plain text and automatic identification (linear or 2D barcode)
MDR Annex VI Part C: UDI in separate AIDC carrier unless technically not feasible
801.45(c): IFU identified by UDI-DI only (production identifiers not required)
21 CFR 830: Global Unique Device Identification Database submission required
830.310: Publish UDI data no later than commercial distribution date
830.320: Update device information when changes affect existing GUDID data
MDR Article 29: UDI database registration required for CE-marked devices
801.45(d): Permanent direct marking required for reusable/reprocessed devices
801.45(d)(2): UDI must remain legible through sterilization, cleaning cycles
801.45(e): Class III implantables require UDI on device (if feasible) and implant card
Best practice: Verify UDI against GUDID/EUDAMED at distribution points
ISO 15415/16: Verify barcode quality meets minimum grade standards
Supply chain efficiency: Include UDI in EDI transactions for traceability
FDA: Class III (Sept 2014), Class II (Sept 2016), Class I (Sept 2020)
801.30: Limited exceptions for device limitations, single-use devices, etc.
Please answer all required questions to see your results